469 Combining a safe PI3Kd inhibitor with chemotherapy and anti-PD1 in immunotherapy-refractory NSCLC: a proof-of-concept study to allow clinical trial design
| Autor: | Silvia Novello, Chiara Riganti, Luisella Righi, Fabrizio Tabbò, Lars van der Veen, Michael Lahn, Giusy Di Conza, Giorgio Scagliotti, Laurence Neff |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2051-1426 |
| DOI: | 10.1136/jitc-2023-SITC2023.0469 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|